EM John, A Miron, G Gong, AI Phipps, A … - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Information on ... Cited by 37 - Related articles - BL Direct - All 3 versions
- ►eurekalert.org [PDF] JD Fackenthal, OI Olopade - Nature Reviews Cancer, 2007 - medscape.com Germline mutations in the BRCA1 or BRCA2 tumour-suppressor genes are strong
predictors of breast and/or ovarian cancer development. The contribution of
these mutations to breast cancer risk within any specific population is a ... Cited by 38 - Related articles - BL Direct - All 10 versions
- ►aacrjournals.org MA Carvalho, SM Marsillac, R Karchin, S … - Cancer Research, 2007 - AACR The breast and ovarian cancer predisposition gene BRCA1 displays large allelic
diversity with several thousand different alleles documented thus far (Breast
Cancer Information Core Database). 16 This is consistent with the expected ... Cited by 33 - Related articles - BL Direct - All 7 versions
FP Liebens, B Carly, A Pastijn, S Rozenberg - European Journal of Cancer, 2007 - Elsevier The optimal clinical management of breast cancer (BC) arising in BRCA1/2
mutations carriers is a difficult issue complicated by the risk of subsequent
malignancies and by the potential differences in response to local and ... Cited by 20 - Related articles - All 15 versions
JC Figueiredo, M Ennis, JA Knight, JR … - Breast Cancer Research and Treatment, 2007 - Springer Abstract Purpose The objective of this study was to examine the association of:
(i) diagnosis at age £35, (ii) first- degree family history of breast or
ovarian cancer (BOC) and (iii) a research based definition of genetic risk, ... Cited by 14 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org LA Brinton, ME Sherman, JD Carreon, WF … - JNCI Journal of the National Cancer Institute, 2008 - jnci.oxfordjournals.org Increases in the incidence of postmenopausal breast cancers have been linked to
screening and menopausal hormone use, but younger women have received less
attention. Thus, we analyzed trends in breast cancer incidence (N = 387 ... Cited by 10 - Related articles - All 7 versions
JP Evans, C Skrzynia, L Susswein, M Harlan - Breast disease, 2006 - IOS Press Abstract. While many individual risk factors have been defined for breast
cancer, a family history was recognized long ago as one of the most potent.
Mutations within BRCA1 or BRCA2, both identified about 10 years ago, are ... Cited by 9 - Related articles - BL Direct - All 5 versions
L Fejerman, E Ziv - Pharmacogenomics, 2008 - Future Medicine Breast cancer incidence and mortality vary among different populations.
African–American, Hispanic, Asian and Native American women have lower
incidence but higher mortality compared with non-Hispanic white women. ... Cited by 6 - Related articles - BL Direct - All 11 versions
K Innos, PL Horn-Ross - Breast Cancer Research and Treatment, 2008 - Springer Abstract Background The diagnosis of ductal carcinoma in situ (DCIS) has become
increasingly common, but it is not clear which factors predict the development
of subsequent breast cancers in these women. The risk of second primary ... Cited by 4 - Related articles - All 2 versions
TA Scholl, WW Noll - Cancer, 2009 - interscience.wiley.com In women at increased risk for breast and ovarian cancer, the identification of
a mutation in breast cancer gene 1 (BRCA1) and BRCA2 has important implications
for screening and prevention counseling. Uncertainty regarding the role of ... Cited by 3 - Related articles - All 3 versions
